Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactured for: Apotex Corp., Weston, FL 33326. NDC 60505-2742-

FDA recall notice · announced October 7, 2015 · Apotex

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactured for: Apotex Corp., Weston, FL 33326. NDC 60505-2742-5.

Reason for recall

Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.

Notes

Distribution: Nationwide and Puerto Rico
Lot/code information: Lot #: KP2621, Exp 8/2015
Quantity: 2,075 bottles
Status: Terminated
Products in this recall event:
- Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactur (D1834-2015)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.